Aptamer–ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy
Oligonucleotides (ODNs) such as siRNA, saRNA, and miRNA regulate gene expression through a variety of molecular mechanisms and show unique potential in the treatment of genetic diseases and rare diseases, but their clinical application is still limited by the efficiency of the delivery system, espec...
Saved in:
| Main Authors: | Bei Xia, Qubo Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/10/697 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management
by: Wang Dui, et al.
Published: (2025-03-01) -
The RNA revolution in medicine: from gene regulation to clinical therapeutics
by: Jiwon Jeong, et al.
Published: (2025-12-01) -
Development of conditional-siRNA programmable riboswitch for targeting adverse cardiac remodeling
by: Priyanka Gokulnath, et al.
Published: (2025-09-01) -
Target mRNA abundance dilutes microRNA and siRNA activity
by: Aaron Arvey, et al.
Published: (2010-04-01) -
Aptamer-conjugation targets decoy-ODN-therapeutics to liver fibrosis
by: Larissa W. Picard, et al.
Published: (2025-09-01)